Take Ltd

Take Limited, formerly known as TAKE Solutions Limited, has set Tuesday, September 22, 2026, as the cut-off date to determine eligibility for members to vote through remote e-voting and e-voting during its 25th Annual General Meeting, scheduled for September 29, 2026, at 12:00 P.M. (IST). The remote e-voting facility will be available from Saturday, September 26, 2026, at 09:00 A.M. (IST) to Monday, September 28, 2026, at 05:00 P.M. (IST).

Take Limited, formerly known as Take Solutions Limited, announced that its board of directors re-appointed Parmeshvar Dhangare as a Non-Executive Non-Independent Director, liable to retire by rotation, and appointed M/s. A. Raghavendra Rao & Associates as Statutory Auditors for a period of five years commencing from fiscal year 2026-27 till fiscal year 2030-31. The company will hold its 25th Annual General Meeting on Tuesday, September 29, 2026, at 12:00 P.M. through Video Conferencing/Other Audio-Visual Means, with remote e-voting commencing on Saturday, September 26, 2026, and concluding on Monday, September 28, 2026.

TAKE Limited, formerly known as TAKE Solutions Limited, informed the Bombay Stock Exchange and National Stock Exchange of India that its board of directors approved the appointment of M/s. Tejas Nadkarni & Associates, Chartered Accountants (FRN: 135197W), as the company's Internal Auditor for the financial year 2025-26, effective September 1, 2026, for a term of one year.

Take Solutions Ltd share price ticked higher by 0.66% to Rs 22.99. The Company's net profit plunged by 75.69% to Rs 1.06 crore, while revenue from operations nosedived 43.96% to Rs 30.37 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 40449.79 crore, falling 12.98%. It has marginally improved by 2.77% over last one week and moving up by 9.17% in last one month while the market capitalization of Take Solutions Ltd has inched up 3.79% and 17.55% in the same period respectively. Profit before tax (PBT) of Take Solutions Ltd stood at Rs 1.06 crore in Q2 FY26, crashing by 216.48% year-on-year, and nosediving by 75.69% quarter-on-quarter. EBITDA came in at Rs 2 crore, jumping 224.49% YoY and tanking 73.54% sequentially. Total expenses saw a steep drop of 44.30% to Rs 30.64 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 0.07 crore, witnessing a strong rise of 600% YoY. For the TTM ended FY26, revenue from operations sank 100% , while net profit witnessed a sharp fall of 101.11% to Rs 0.74 crore, compared to previous TTM. EBITDA tumbled by 2367% to Rs 17.69 crore, and PBT collapsed by 101.19% to Rs 0.74 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 16.37 crore in FY26, as against Rs 9.32 crore in FY25. Take Solutions Ltd surged by 155.44% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.

Take Limited, formerly known as Take Solutions Limited, will hold a board meeting on Tuesday, August 11, 2026, at its registered office to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Net profit of Take Solutions reported to Rs 4.36 crore in the quarter ended March 2026 as against net loss of Rs 4.88 crore during the previous quarter ended March 2025. Sales reported to Rs 54.19 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025. For the full year,net profit declined 71.04% to Rs 10.85 crore in the year ended March 2026 as against Rs 37.47 crore during the previous year ended March 2025. Sales reported to Rs 54.19 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales54.190 0 54.190 0 OPM %-1.510 --3.520 - PBDT4.360.31 1306 4.430.78 468 PBT4.360.30 1353 4.420.74 497 NP4.36-4.88 LP 10.8537.47 -71 Powered by Capital Market - Live

Take Solutions will hold a meeting of the Board of Directors of the Company on 20 May 2026.

The company plans to build a portfolio of science-backed nutraceuticals, biohacking products and digital wellness solutions targeting India's growing health-conscious consumer base. The strategy combines product innovation with technology-enabled platforms aimed at improving metabolic health, sleep, cognition and biological aging. Take Solutions said it will leverage its existing capabilities in clinical research, life sciences and regulatory processes to develop scalable and clinically credible offerings in the segment. The move comes amid strong growth in the global longevity market, which is projected to expand from $27.61 billion in 2025 to $67.03 billion by 2035. In India, rising awareness around preventive healthcare and lifestyle diseases is driving demand for anti-aging products and services. The company aims to build a diversified revenue stream across consumer health products, services and digital platforms as it taps into a market characterized by repeat consumption and improving margins. Take Solutions operates as a technology-driven healthcare solutions provider with a focus on life sciences and supply chain industries. On a consolidated basis, Take Solutions' net profit plunged 97.67% YoY to Rs 1.11 crore in Q3 December 2025 from Rs 47.68 crore in Q3 December 2024. The company reported no sales in both the current and corresponding previous quarter.

Take Solutions announced the launch of its Innovation Fund with an initial corpus commitment of Rs. 5 crore. The fund is aimed at identifying, investing in, and scaling high-potential startups operating at the convergence of Artificial Intelligence (AI), deep technology, and the rapidly expanding health and wellness sector. The initiative underscores Take Solutions' strategic pivot towards enabling next-generation, technology led business models while creating long-term value for stakeholders. The Innovation Fund will focus on early- and growth-stage companies that are leveraging data, AI, and scientific innovation to transform healthcare delivery, diagnostics, and human health outcomes.

Net profit of Take Solutions declined 97.67% to Rs 1.11 crore in the quarter ended December 2025 as against Rs 47.68 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live